MENU
+Compare
ANEB
Stock ticker: NASDAQ
AS OF
Apr 4, 01:53 PM (EDT)
Price
$1.03
Change
-$0.05 (-4.63%)
Capitalization
44.37M

ANEB Anebulo Pharmaceuticals Forecast, Technical & Fundamental Analysis

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction... Show more

ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ANEB with price predictions
Apr 03, 2025

ANEB's Stochastic Oscillator is remaining in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +3 3-day Advance, the price is estimated to grow further. Considering data from situations where ANEB advanced for three days, in of 140 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ANEB moved out of overbought territory on March 21, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 11 similar instances where the indicator moved out of overbought territory. In of the 11 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on March 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ANEB as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ANEB turned negative on March 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

ANEB moved below its 50-day moving average on March 27, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ANEB crossed bearishly below the 50-day moving average on April 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANEB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ANEB broke above its upper Bollinger Band on March 19, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ANEB entered a downward trend on March 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.966) is normal, around the industry mean (13.581). P/E Ratio (0.000) is within average values for comparable stocks, (64.662). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.879). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (248.206).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ANEB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ANEB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ANEB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ANEB is expected to report earnings to fall 11.11% to -7 cents per share on May 08

Anebulo Pharmaceuticals ANEB Stock Earnings Reports
Q1'25
Est.
$-0.08
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.03
Q2'24
Beat
by $0.06
Q1'24
Beat
by $0.06
The last earnings report on February 14 showed earnings per share of -9 cents, missing the estimate of -7 cents. With 12.51K shares outstanding, the current market capitalization sits at 44.37M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1017 Ranch Road 620 South
Phone
+1 512 598-0931
Employees
2
Web
https://www.anebulo.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRGGX39.16N/A
N/A
MFS Core Equity R1
HHDFX35.18N/A
N/A
Hamlin High Dividend Equity Instl
AZMIX16.42N/A
N/A
Virtus NFJ Emerging Markets Value Ins
GFFDX77.55N/A
N/A
Invesco Global Focus R5
LFMGX18.33N/A
N/A
Lord Abbett Micro Cap Growth F

ANEB and Stocks

Correlation & Price change

A.I.dvisor tells us that ANEB and TECX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANEB and TECX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANEB
1D Price
Change %
ANEB100%
-6.09%
TECX - ANEB
28%
Poorly correlated
-6.82%
ALDX - ANEB
28%
Poorly correlated
-73.33%
BCTX - ANEB
26%
Poorly correlated
-3.05%
FBIO - ANEB
26%
Poorly correlated
-5.59%
INSM - ANEB
25%
Poorly correlated
-0.15%
More